Technology
Team
Contact
News & Publications
August 2023
KinCon biolabs Graduates from Creative Destruction Lab (CDL) Program and Joins CDL Supersession in Toronto
August 2023
KinCon biolabs GmbH Receives Health Hub Tirol Funding
June 2023
Tracking and blocking interdependencies of cellular BRAF-MEK oncokinase activities
October 2022
Resistor: An algorithm for predicting resistance mutations via Pareto optimization over multistate protein design and mutational signatures
April 2021
mTORC2 controls the activity of PKC and Akt by phosphorylating a conserved TOR interaction motif
March 2020
Allosteric Kinase Inhibitors Reshape MEK1 Kinase Activity Conformations in Cells and In Silico
November 2020
Mutation-oriented profiling of autoinhibitory kinase conformations predicts RAF inhibitor efficacies
February 2020
KinCon: Cell‐based recording of full‐length kinase conformations
August 2019
BRAF inhibitors promote intermediate BRAF(V600E) conformations and binary interactions with activated RAS
June 19, 2024
KinCon biolabs Graduates from Creative Destruction Lab (CDL) Program and Joins CDL Supersession in Toronto
June 19, 2024
KinCon biolabs GmbH Receives Health Hub Tirol Funding
September 8, 2023
Tracking and blocking interdependencies of cellular BRAF-MEK oncokinase activities
November 15, 2022
Resistor: An algorithm for predicting resistance mutations via Pareto optimization over multistate protein design and mutational signatures
September 27, 2022
mTORC2 controls the activity of PKC and Akt by phosphorylating a conserved TOR interaction motif
September 27, 2022
Allosteric Kinase Inhibitors Reshape MEK1 Kinase Activity Conformations in Cells and In Silico
September 27, 2022
Mutation-oriented profiling of autoinhibitory kinase conformations predicts RAF inhibitor efficacies
September 27, 2022
KinCon: Cell‐based recording of full‐length kinase conformations
September 27, 2022
BRAF inhibitors promote intermediate BRAF(V600E) conformations and binary interactions with activated RAS